Niclosamide ethanolamine ameliorates diabetes-related muscle wasting by inhibiting autophagy
Open Access
- 9 June 2021
- journal article
- research article
- Published by Springer Nature in Skeletal Muscle
- Vol. 11 (1) , 1-10
Abstract
Background: Diabetes-related muscle wasting is one of the devastating complications of diabetes, which is associated with muscle autophagy due to insulin-mediated glucose starvation. However, treatment for diabetes-related muscle wasting is limited. Our previous study already found that niclosamide ethanolamine salt has the therapeutic effects on insulin deficiency of type 1 diabetes mice and muscle wasting induced by doxorubicin. Therefore, we aim to investigate the therapeutic effects of niclosamide ethanolamine salt on diabetes-induced muscle wasting and to explore whether the mechanism is associated with muscle autophagy. Methods: Type 1 diabetes mice were induced by intraperitoneal injection of streptozotocin, then were fed with regular diet supplemented with 10 g/kg niclosamide ethanolamine salt. The whole experiment lasted for 8 weeks. At the end of the study, grip strength, weights of tibialis anterior, gastrocnemius, soleus, and extensor digitorum longus muscle were measured. Tibialis anterior muscles stained with PAS were used for evaluating the fiber cross sectional area. Immunofluorescence analysis of myosin heavy chain expression in extensor digitorum longus and soleus muscle was used for determining the composition of the muscle fiber type. Electronic microscopy was applied to observe the autophagy in the atrophied muscle. Serum insulin levels and fasting blood glucose were also measured. Tissues of gastrocnemius muscle were used for detecting the expression of the proteins related to autophagy. Results: In this study, we found that niclosamide ethanolamine salt could ameliorate muscle atrophy in the type 1 diabetes mice as well, such as enhancing the declined grip strength, improving limb weight and increasing the numbers of glycolytic muscle fiber. Electron microscopy also confirmed that there did exist abundant autophagic vacuoles in the atrophied muscle of the type 1 diabetes mice. Specifically, niclosamide ethanolamine salt could reduce the over expression of autophagy-related proteins, including p-AMPK (Thr172), FoxO3a, p-ULK1 (Ser555), LC3B II, and p-p38 in gastrocnemius muscle of the type 1 diabetes mice. Conclusion: Niclosamide ethanolamine salt could ameliorate muscle wasting. The mechanisms underlying might be associated with inhibition of muscle autophagy.Keywords
This publication has 27 references indexed in Scilit:
- Mechanisms regulating skeletal muscle growth and atrophyThe FEBS Journal, 2013
- Motor dysfunction in diabetesDiabetes/Metabolism Research and Reviews, 2012
- The Role of Atg Proteins in Autophagosome FormationAnnual Review of Cell and Developmental Biology, 2011
- AMPK promotes skeletal muscle autophagy through activation of forkhead FoxO3a and interaction with Ulk1Journal of Cellular Biochemistry, 2011
- Phosphorylation of ULK1 (hATG1) by AMP-Activated Protein Kinase Connects Energy Sensing to MitophagyScience, 2011
- Toll‐like receptor 4 mediates lipopolysaccharide‐induced muscle catabolism via coordinate activation of ubiquitin‐proteasome and autophagy‐lysosome pathwaysThe FASEB Journal, 2010
- p38 MAPK links oxidative stress to autophagy-related gene expression in cachectic muscle wastingAmerican Journal of Physiology-Cell Physiology, 2010
- FoxO3 Controls Autophagy in Skeletal Muscle In VivoCell Metabolism, 2007
- Effect of Insulin Deprivation on Muscle Mitochondrial ATP Production and Gene Transcript Levels in Type 1 Diabetic SubjectsDiabetes, 2007
- Histochemical properties of skeletal muscle fibers in streptozotocin-diabetic ratsCell and tissue research, 1975